Related Experiment Videos
[Preoperative eye-drop antibiotherapy in cataract surgery]
E Fernández Rubio1, T Cuesta Rodríguez, C Cortés Valdés
1Hospital General Universitario Gregorio Marañón, Departamento de Oftalmología, Laboratorio de Análisis Clínicos del Instituto Oftálmico, Madrid, Spain. mfernandezr.hgugm@salud.madrid.org
Archivos De La Sociedad Espanola De Oftalmologia
|June 3, 2004
Summary
No single antibiotic eye-drop effectively eradicates preoperative conjunctival bacteria for cataract surgery. Treatment effectiveness decreases with polymicrobial infections, necessitating optimized therapeutic strategies.
Area of Science:
- Ophthalmology
- Microbiology
- Pharmacology
Context:
- Cataract surgery requires preoperative conjunctival bacterial eradication.
- Antibiotic eye-drops are commonly used for this purpose.
- Understanding treatment efficacy and failure mechanisms is crucial.
Purpose:
- To evaluate the effectiveness of five antibiotic eye-drops in clearing preoperative conjunctival bacteria.
- To distinguish between treatment failure due to bacterial resistance and other causes.
- To identify optimal antibiotic choices for specific bacterial pathogens.
Summary:
- A retrospective study analyzed 4876 patients' conjunctival flora and antibiotic susceptibility.
- Chloramphenicol and Rifampicin showed high in vitro susceptibility, but clinical failures occurred.
- Gentamicin was effective against Staphylococcus aureus and Gram-negative rods; Aureomicin against Streptococcus and Gram-negative diplococci; Rifamicin against Gram-positive flora.
- Polymicrobial infections significantly reduced the effectiveness of all tested monotherapies.
Impact:
- None of the evaluated antibiotic monotherapies ensured a pathogen-free conjunctiva 48 hours post-treatment.
- Findings suggest potential for optimizing antibiotic regimens.
- The presence of multiple bacterial species complicates eradication and necessitates further research into combination therapies or alternative strategies.